BioSpace News Archive

Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs announced that it mapped the mutations found in Delta and the other variants of concern identified to date and determined that the majority of the mutations are in the Spike protein and only a few fall within the genomic sequences that encode nsp3, a multi-domain protein that includes the PLpro enzyme.

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provided additional information regarding the status of its randomized, double-blind, placebo-controlled Phase 2 clinical trial of Brilacidin for the treatment of moderate-to-severe COVID-19 in hospitalized patients (see NCT04784897).

Zealand Pharma Launches ZEGALOGUE® (dasiglucagon) Injection and Advances Pipeline Programs Across Multiple Therapeutic Areas

Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, announced today that Dominic Clarke, Ph.D. has joined the company as Chief Technical Officer of Cell & Gene Therapy.

Medcura, Inc., a commercial-stage medical device company, today announced it has raised $7.4 million in private equity to support its growing product line and development of its lead surgical candidate for clinical evaluation.

FibroBiologics, a clinical stage company developing fibroblast-based therapeutic solutions for chronic diseases, today announced the appointment of Hamid Khoja, Ph.D. as Chief Scientific Officer.

The market is estimated to grow at a CAGR of 5.5% from 2020 to 2027.

The report highlights trends prevailing in the global non-invasive cardiac output monitoring device market and factors governing the market growth.

The market is estimated to grow at a CAGR of 13.4% from 2020 to 2027.

The report highlights the trends prevalent in the global bone cement market and the factors driving the market along with those that act as deterrents to its growth.